Future Tech Head-to-head trial shows Eli Lilly’s oral GLP-1 orforgaliprone outperforms oral semaglutide by February 27, 2026 February 27, 2026 26 February 2026 4 read minutes Add us on GoogleAdd SciAm Head-to-head trial of Eli Lilly’s oral GLP-1 against oral semaglutide underlines efficacy of weight-loss pills A new trial found … 0 FacebookTwitterPinterestEmail
